Home > Archive>Volume 15, Issue 2, 2022 >189-196. DOI:10.18240/ijo.2022.02.01
PDF HTML XML Export Cite reminder
Inhibitory effect on subretinal fibrosis by anti-placental growth factor treatment in a laser-induced choroidal neovascularization model in mice
Author:
Corresponding Author:

Ai-Yi Zhou. Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, No.157 West Five Road, Xi'an 710004, Shaanxi Province, China. sandy-_chow@126.com

Fund Project:

Supported by the Shaanxi Key Research and Development Program-General Project in the Field of Social Development (No.2017SF-140).

  • Article
    • | |
  • Metrics
    • |
  • Reference [1]
    • |
  • Related
    • | | |
  • Comments
    Abstract:

    AIM: To investigate whether anti-placental growth factor (PGF) can inhibit subretinal fibrosis and whether this effect is mediated by the inhibitory effect of PGF on epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. METHODS: Subretinal fibrosis model was established in laser induced choroidal neovascularization (CNV) mice on day 21 after laser photocoagulation. Immunofluorescence staining (IFS) of cryosections and enzyme-linked immunosorbent assay (ELISA) were used to detect the expression of PGF. IFS of whole choroidal flat-mounts was used to detect the degree of subretinal fibrosis. IFS of cryosections and ELISA were used to detect the expression of EMT related indicators in subretinal fibrosis lesions. RESULTS: The expression of PGF protein in subretinal fibrosis lesions was significantly up-regulated (P<0.05), and mainly co-stained with pan-cytokeratin labeled RPE cells. Intravitreal injection of anti-PGF neutralizing antibody reduced the area of subretinal fibrosis and the ratio of fibrotic/angiogenic area significantly at the concentrations of 0.25, 0.5, 1.0, and 2.0 μg/μL (all P<0.05). The expression of E-cadherin in the local RPE cells decreased, while α-SMA increased significantly in subretinal fibrosis lesions, and the application of anti-PGF neutralizing antibody could reverse these changes (P<0.05). CONCLUSION: The expression of PGF is up-regulated in the lesion site of subretinal fibrosis and mainly expressed in RPE cells. Intravitreal injection of anti-PGF neutralizing antibody can significantly inhibit the degree of subretinal fibrosis in CNV mice, and this effect may be mediated by the inhibition of PGF on EMT of RPE cells.

    Reference
    1 Blasiak J, Petrovski G, Veréb Z, Facskó A, Kaarniranta K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res Int 2014;2014:768026.<br>2 Kodjikian L, Decullier E, Souied EH, Roux A, Aulagner G, Huot L, Group GEFALS. Predictors of one-year visual outcomes after anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration. Retina 2018;38(8):1492-1499.<br>3 Bloch SB, Lund-Andersen H, Sander B, Larsen M. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Am J Ophthalmol 2013;156(1):116-124.e1.<br>4 Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, Huang J, Ying GS, Hagstrom SA, Winter K, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2014;121(3):656-666.<br>5 Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, Jaffe GJ, Toth CA, Martin DF, Fine SL, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials. Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2018;125(7):1037-1046.<br>6 Barikian A, Mahfoud Z, Abdulaal M, Safar A, Bashshur ZF. Induction with intravitreal bevacizumab every two weeks in the management of neovascular age-related macular degeneration. Am J Ophthalmol 2015;159(1):131-137.<br>7 Papadopoulos N, Martin J, Ruan Q, Rafique A, Rosconi MP, Shi EG, Pyles EA, Yancopoulos GD, Stahl N, Wiegand SJ. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 2012;15(2):171-185.<br>8 De FS. The discovery of placenta growth factor and its biological activity. Exp Mol Med 2012;44(1):1-9.<br>9 van de Veire S, Stalmans I, Heindryckx F, et al. Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 2010;141(1):178-190.<br>10 Li X, Jin QW, Yao QY, Zhou Y, Zou YT, Li Z, Zhang SC, Tu CT. Placental growth factor contributes to liver inflammation, angiogenesis, fibrosis in mice by promoting hepatic macrophage recruitment and activation. Front Immunol 2017;8:801.<br>11 Li X, Yao QY, Liu HC, Jin QW, Xu BL, Zhang SC, Tu CT. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease. J Cell Mol Med 2017;21(10):2370-2385.<br>12 Zhang L, Zhao S, Yuan LJ, Wu HM, Jiang H, Luo G. Placental growth factor triggers epithelial-to-mesenchymal transition-like changes in rat type II alveolar epithelial cells: activation of nuclear factor κB signalling pathway. Basic Clin Pharmacol Toxicol 2016;119(5):498-504.<br>13 van Bergen T, Jonckx B, Hollanders K, Sijnave D, van de Velde S, Vandewalle E, Moons L, Stassen JM, Stalmans I. Inhibition of placental growth factor improves surgical outcome of glaucoma surgery. J Cell Mol Med 2013;17(12):1632-1643.<br>14 Zhang L, Zhao S, Yuan LJ, Wu HM, Jiang H, Luo G. Placenta growth factor contributes to cell apoptosis and epithelial-to-mesenchymal transition in the hyperoxia-induced acute lung injury. Life Sci 2016;156:30-37.<br>15 Huang W, Zhu SL, Liu Q, Li CY, Li L. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer. Int J Clin Exp Pathol 2014;7(12):8506-8519.<br>16 Ning Q, Liu CG, Hou L, Meng M, Zhang XJ, Luo MN, Shao S, Zuo XX, Zhao XH. Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition. PLoS One 2013;8(6):e65217.<br>17 Ishikawa K, Kannan R, Hinton DR. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res 2016;142:19-25.<br>18 Ishikawa K, Sreekumar PG, Spee C, Nazari H, Zhu DH, Kannan R, Hinton DR. αB-crystallin regulates subretinal fibrosis by modulation of epithelial-mesenchymal transition. Am J Pathol 2016;186(4):859-873.<br>19 Zhang Y, Zhao L, Wang LJ, Yang XT, Zhou AY, Wang JM. Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia. Mol Vis 2018;24:340-352.<br>20 Xie LQ, Wang Y, Li Q, Ji XY, Tu YY, Du S, Lou H, Zeng XW, Zhu LL, Zhang J, Zhu MH. The HIF-1α/p53/miRNA-34a/Klotho axis in retinal pigment epithelial cells promotes subretinal fibrosis and exacerbates choroidal neovascularization. J Cell Mol Med 2021;25(3):1700-1711.<br>21 Shao J, Choudhary MM, Schachat AP. Neovascular age-related macular degeneration. Dev Ophthalmol 2016;55:125-136.<br>22 Peng XN, Xiao H, Tang M, Zhan ZY, Yang Y, Sun LM, Luo XL, Zhang AY, Ding XY. Mechanism of fibrosis inhibition in laser induced choroidal neovascularization by doxycycline. Exp Eye Res 2018;176:88-97.<br>23 Hollanders K, van Bergen T, Kindt N, Castermans K, Leysen D, Vandewalle E, Moons L, Stalmans I. The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2015;56(2):1335-1348.<br>24 Souied EH, Addou-Regnard M, Ohayon A, Semoun O, Querques G, Blanco-Garavito R, Bunod R, Jung C, Sikorav A, Miere A. Spectral-domain optical coherence tomography analysis of fibrotic lesions in neovascular age-related macular degeneration. Am J Ophthalmol 2020;214:151-171.<br>25 Akhtar-Schäfer I, Wang LP, Krohne TU, Xu HP, Langmann T. Modulation of three key innate immune pathways for the most common retinal degenerative diseases. EMBO Mol Med 2018;10(10):e8259.<br>26 Balser C, Wolf A, Herb M, Langmann T. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina. J Neuroinflammation 2019;16(1):26.<br>27 Crespo-Garcia S, Corkhill C, Roubeix C, Davids AM, Kociok N, Strauss O, Joussen AM, Reichhart N. Inhibition of placenta growth factor reduces subretinal mononuclear phagocyte accumulation in choroidal neovascularization. Invest Ophthalmol Vis Sci 2017;58(12): 4997-5006.<br>28 Huo XC, Li YX, Jiang YH, Sun XY, Gu LX, Guo WS, Sun DP. Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF. Cell Physiol Biochem 2015;35(5):1787-1796.<br>29 Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM, Haley JD. A systems view of epithelial–mesenchymal transition signaling states. Clin Exp Metastasis 2011;28(2):137-155.<br>30 O'Connor JW, Gomez EW. Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med 2014;3(1):23.<br>31 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014;15(3):178-196.<br>32 Chen YW, Ge WS, Xu LM, Qu CY, Zhu MJ, Zhang WZ, Xiao YT. miR-200b is involved in intestinal fibrosis of Crohn's disease. Int J Mol Med 2012;29(4):601-606.<br>33 Li HF, Jin YP, Hu YP, Jiang L, Liu FT, Zhang YJ, Hao YJ, Chen SL, Wu XS, Liu YB. The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer. Cancer Sci 2018;109(5): 1532-1544.<br>34 Uemura A, Fruttiger M, D'Amore PA, de Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 2021;84:100954.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yi Zhang, Ding-Ying Liao, Jian-Ming Wang,/et al.Inhibitory effect on subretinal fibrosis by anti-placental growth factor treatment in a laser-induced choroidal neovascularization model in mice. Int J Ophthalmol, 2022,15(2):189-196

Copy
Share
Article Metrics
  • Abstract:1032
  • PDF: 819
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:November 24,2020
  • Revised:December 10,2021
  • Online: January 26,2022
You are the 4410245 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.